Thyroid Microcarcinoma Prognosis Data with Postoperative Thyroglobulin Measurements

A retrospective study of 150 differentiated thyroid carcinoma patients, with 54 cases of microcarcinoma, assessed for disease persistence or recurrence. The dataset includes first postoperative stimulated thyroglobulin measurements, treatment details, and follow-up times. It was created by Isabela de Oliveira Amui and is available via paperswithcode.

Use Cases

• Predicting disease persistence or recurrence in thyroid microcarcinoma based on first postoperative stimulated thyroglobulin levels.
• Analyzing the relationship between accumulated 131iodine dose and patient prognosis.
• Identifying risk factors for worse outcomes using multivariate logistic regression on clinical parameters.

Strengths

• Includes data from 150 patients, with a specific focus on 54 microcarcinoma cases.
• Provides specific statistical results, such as a cutoff point of 1.6 ng/dL for thyroglobulin associated with disease persistence/recurrence.
• Contains detailed clinical parameters like follow-up time (up to approximately 103 months) and accumulated 131iodine dose.

Limitations

• Row count for the underlying dataset is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

paperswithcode

Collection Method

Retrospective study of medical records.